Table of Contents

Albumin (as Excipient) Market Outlook, | Forecast

The Albumin (as Excipient) Market is expected to grow at a CAGR of 5.9% and is expected to reach a value of USD 1.46 billion during the forecast period.
Albumin (as Excipient) Market

Market Overview

The Albumin (as Excipient) Market is expected to grow at a CAGR of 5.9% and is expected to reach a value of USD 1.46 billion during the forecast period. When it comes to the manufacture of drugs, the choice of excipient is crucial. Albumin has been proven to improve the lyophilized cake shape, the melting qualities of API from lyophilized granules, and the mobility of the drug substance when employed as an excipient in the preparation. The rising use of transgenic albumin-based drug carriers by biotechnology and pharmaceutical companies is one of the major factors driving the albumin industry. GlaxoSmithKline plc is using Novozymes Biopharma DK A/S’ albumin-based VELTIS breakthrough in the production of type II diabetic medications in Europe, according to a recent release.

The rising incidence of chronic diseases, technological innovations, the emergence of new markets in APAC and the Rest of the World, increased awareness of Albumin ┬ámas an excipient, and the rising use of Albumin for non-therapeutic implementations are all expected to contribute to the market’s continued growth. Due to a rise in the occurrence of life-threatening diseases and conditions, such as liver injury, infections, and cardiac surgery, hypoalbuminemia is becoming increasingly widespread. Growing acceptance of albumin products, development of albumin market outlook products for non-therapeutic purposes across various areas, and increased recognition of recombinant Albumin are all contributing to the market’s growth.

Market Segmentation

Based on the Application, the Albumin (as Excipient) Market Report has been segmented into in-vitro fertilization, medical device coating, drug formulation, vaccines, drug delivery, culture medium & stabilizers, diagnostics, and others.

Based on the end-users, the Albumin (as Excipient) Market has been segmented into academic and research organizations, the pharmaceutical and biotechnology sector, and others based on the propulsion types.

Based on the region, the Albumin (as Excipient) Market has been segmented into the Americas, Europe, Asia Pacific, the middle east, and Africa.

Regional Classification

The global market for Albumin was boosted by rising R&D spending and rising diabetes rates in the Americas. According to data from the Centers for Disease Control and Prevention (CDC), around 30.3 million Americans have diabetes. During the historic forecast period, Europe was anticipated to be the second-largest market for Albumin. This is due to technological advancements and increased market participation. During the historic forecast period, it was expected that the Asia-Pacific region would expand the fastest. The Asia Pacific region’s regional marketplaces are driven by an increase in medical spending. Between 2015 and 2016, the Australian Institute of Health and Welfare reported a total health investment of USD 181 billion. Even though albumin was most popular in Europe and North America, the Middle East and Africa had the smallest share of the total albumin market.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: [email protected]


Blog Tags
Blog Category

Leave a Reply